AML, Adult Clinical Trials in Nantes
4 recruitingNantes, France
Showing 1–4 of 4 trials
Recruiting
OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia
AML, Adult
French Innovative Leukemia Organisation250 enrolled21 locationsNCT06377579
Recruiting
Epidemiological Study of a Prospective Cohort of Patients Aged 60 and Over Managed for Acute Myeloid Leukemia (AML) and Receiving Intensive Induction Therapy
AML, Adult
French Innovative Leukemia Organisation1,000 enrolled27 locationsNCT06891144
Recruiting
Phase 2
Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia
AML, AdultRefractory AMLRelapsed Adult AML+2 more
French Innovative Leukemia Organisation33 enrolled20 locationsNCT06022003
Recruiting
Results From a French Temporary Utilization Authorization of First-line Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Chemotherapy (IC), Treated With Venetoclax Azacitidine
AML, Adult
French Innovative Leukemia Organisation230 enrolled42 locationsNCT06263387